News and Trends 20 Dec 2022Verona Pharma drug meets COPD phase 3 trial endpoints Verona Pharma plc has announced positive results of its phase 3 ENHANCE-1 trial evaluating nebulized ensifentrine for the maintenance treatment… December 20, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 18 Oct 2022Progress of COPD drug boosted by debt financing of up to $150M Verona Pharma plc has today (October 17) announced that it has entered into a debt financing facility providing access of… October 18, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2022More positive news announced for Verona’s COPD treatment Clinical-stage biopharmaceutical company, Verona, has announced more positive news from its phase 3 ENHANCE-2 clinical trial of ensifentrine that treats… October 17, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 19 Aug 2022Nuance Pharma receives clearance to begin clinical trials with Ensifentrine in China Nuance Pharma and its partner Verona Pharma plc have received clearance from the Center of Drug Evaluation for the investigational… August 19, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
More News! 5 Aug 2019Phase II Promise for Inhaled Chronic Lung Disease Treatment A first-in-class inhaled drug developed by the UK biotech Verona Pharma improved lung function in a phase II trial treating… August 5, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 14 Jan 2019Inhaled Lung Disease Treatment Encounters Mixed Results in Phase II Trial An inhaled drug from British company Verona Pharma has failed to significantly improve lung function in patients with the lung… January 14, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 20 Jun 2018“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech Some careers take on an international scope and span the breadth of big players in the pharmaceutical industry and small… June 20, 2018 - 9 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 7 Sep 2017Verona Achieves Successful Results for Phase IIa Trial of Deadly Lung Disease Drug A study of Verona's combination therapy for COPD observed a clinical improvement in lung function and faster onset-of-action. Verona filed… September 7, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jul 2017Update: Potential Breakthrough Treatment for Deadly Lung Disease Starts Phase IIb Update (26/07/2017): Verona Pharma has dosed the first patients in the PhaseIIb with RPL554 in patients with chronic obstructive pulmonary disease… July 26, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 19 Apr 2017UPDATE: Verona sets terms & dials back its IPO goal to a still-hefty €75M UPDATE: Verona set the terms for its US IPO yesterday and knocked $10M (€9.3M) off its target, now shooting for $75M (€70M). … April 19, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email